“Precision medicine is a healthcare approach that utilises molecular information, phenotypic and health data from patients to generate care insights to prevent or treat human disease resulting in improved health outcomes”

The EFPIA Precision Medicine Working Group

Precision Medicine Market

Precision Medicine Market graph
73% Oncology
14% Nervous System Disorder
8% Respiratory & Circulatory Disorders
5% Other

There is a huge opportunity for Precision Medicine in new medical areas such as autoimmune diseases, chronic inflammation associated pathologies, cardiovascular medicine or aging.

Our Pipeline

Our Focus for future developments : Chronic conditions

  • Prognostic molecular signature in different pediatric solid tumors
  • Prognostic molecular signature for rheumatic diseases & chronic
    inflammatory diseases
  • Immunooncology prognostic signature
  • Chronic hepatic diseases prognostic signature
  • Ageing signature by exosome genomics
  • Predisposition to Prostate, Ovarian, Breast Cancer (germinal panel)
  • Myelodysplasia, Myeloblastic leukemia, Chronic myeloproliferative neoplasms
  • Colon ca, Lung ca, Melanoma (OFA)
  • BRCA1 y 2
  • Liquid biopsy (ctDNA PanCancer assay) Ca lung, Ca colon, Melanoma, Breast and Ovarian
  • Prostate, Ovarian, Breast Cancer (HRR)
  • B and T Lymphoma
  • Glioblastoma, Cholangiocarcinoma and Myeloblastic Leukemia (IDH1 and 2)
  • Hereditary Colon Cancer (MLH1 Methylation)
  • Rare Diseases (HHT, FOP, Amyloidosis)
  • Breast cancer recurrence score test

Contact Us

Feel free to contact us with questions, potential partnerships or media inquiries